clinical trial Archives
Oct. 16, 2020—Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
Oct. 13, 2020—AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.
Sep. 2, 2020—Vanderbilt University Medical Center is now enrolling volunteers for a clinical trial of promising treatments for COVID-19 in the outpatient setting.
Jul. 15, 2020—In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
Jul. 14, 2020—An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.
Apr. 23, 2020—Vanderbilt University Medical Center is participating in a multisite clinical trial to test a potential new medication for treating core deficits of autism spectrum disorders in children ages 2-4.
Feb. 13, 2020—Vanderbilt is testing a device to assist in locating parathyroid glands during surgery.
Dec. 5, 2019—The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.
Sep. 4, 2019—A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.
Aug. 14, 2019—Scarcely a year after its national launch, the “All of Us” research program, which aims to accelerate the prevention and treatment of disease, has enrolled more than 230,000 research participants — more than a fifth of its recruitment goal of 1 million people. All
Jul. 8, 2019—A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.